| Member Country | Concept ID | Fully Specified Name | Preferred Term (local) | Other Info |
|---|---|---|---|---|
UK | 39115611000001103 | COVID-19 mRNA Vaccine Pfizer-BioNTech BNT162b2 30micrograms/0.3ml dose concentrate for suspension for injection multidose vials (Pfizer Ltd) (product) | COVID-19 mRNA Vaccine Pfizer-BioNTech BNT162b2 30micrograms/0.3ml dose concentrate for suspension for injection multidose vials (Pfizer Ltd) | AMP |
UK | 39115711000001107 | COVID-19 mRNA Vaccine Pfizer-BioNTech BNT162b2 30micrograms/0.3ml dose concentrate for suspension for injection multidose vials (Pfizer Ltd) 6 dose (product) | COVID-19 mRNA Vaccine Pfizer-BioNTech BNT162b2 30micrograms/0.3ml dose concentrate for suspension for injection multidose vials (Pfizer Ltd) 6 dose | AMPP |
UK | 39214511000001101 | COVID-19 mRNA Vaccine Pfizer-BioNTech BNT162b2 30micrograms/0.3ml dose concentrate for suspension for injection multidose vials (Pfizer Ltd) 1170 dose 195 x 6 dose vials (product) | COVID-19 mRNA Vaccine Pfizer-BioNTech BNT162b2 30micrograms/0.3ml dose concentrate for suspension for injection multidose vials (Pfizer Ltd) 1170 dose – 195 x 6 dose vials | AMPP GTIN: 00359267100023 |
UK | 39114911000001105 | COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (AstraZeneca UK Ltd) (product) | COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (AstraZeneca) | AMP |
UK | 39115011000001105 | COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (AstraZeneca UK Ltd) 8 dose (product) | COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (AstraZeneca) 8 dose | AMPP |
UK | 39115111000001106 | COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (AstraZeneca UK Ltd) 10 dose (product) | COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (AstraZeneca) 10 dose | AMPP |
UK | 39301211000001105 | COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (AstraZeneca UK Ltd) 80 dose 10 x 8 dose vials (product) | COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (AstraZeneca) 80 dose 10 x 8 dose vials | AMPP GTIN: 05000456063876 |
UK | 39301311000001102 | COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (AstraZeneca UK Ltd) 100 dose 10 x 10 dose vials (product) | COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (AstraZeneca) 100 dose 10 x 10 dose vials | AMPP GTIN: 05000456063821 |
UK | 39230211000001104 | Astute 100,000,000,000 (100 billion) viral particles/0.5ml dose solution for injection multidose vials (Janssen-Cilag Ltd) (product) | Astute 100,000,000,000 (100 billion) viral particles/0.5ml dose solution for injection multidose vials (Janssen-Cilag Ltd) | AMP |
UK | 39230311000001107 | Astute 100,000,000,000 (100 billion) viral particles/0.5ml dose solution for injection multidose vials (Janssen-Cilag Ltd) 5 dose (product) | Astute 100,000,000,000 (100 billion) viral particles/0.5ml dose solution for injection multidose vials (Janssen-Cilag Ltd) 5 dose | AMPP |
UK | 39230411000001100 | Astute 100,000,000,000 (100 billion) viral particles/0.5ml dose solution for injection multidose vials (Janssen-Cilag Ltd) 50 dose 10 x 5 dose vials (product) | Astute 100,000,000,000 (100 billion) viral particles/0.5ml dose solution for injection multidose vials (Janssen-Cilag Ltd) 50 dose | AMPP |
UK | 39326911000001101 | COVID-19 mRNA (nucleoside modified) Vaccine Moderna 0.1mg/0.5mL dose dispersion for injection multidose vials (Moderna, Inc) (product) | COVID-19 mRNA (nucleoside modified) Vaccine Moderna 0.1mg/0.5mL dose dispersion for injection multidose vials (Moderna, Inc) | AMP |
UK | 39375411000001104 | COVID-19 mRNA (nucleoside modified) Vaccine Moderna 0.1mg/0.5mL dose dispersion for injection multidose vials (Moderna, Inc) 10 dose (product) | COVID-19 mRNA (nucleoside modified) Vaccine Moderna 0.1mg/0.5ml dose dispersion for injection multidose vials (Moderna, Inc) 10 dose | AMPP |
UK | 39327011000001102 | COVID-19 mRNA (nucleoside modified) Vaccine Moderna 0.1mg/0.5mL dose dispersion for injection multidose vials (Moderna, Inc) 100 dose 10 x 10 dose vials (product) | COVID-19 mRNA (nucleoside modified) Vaccine Moderna 0.1mg/0.5ml dose dispersion for injection multidose vials (Moderna, Inc) 100 dose 10 x 10 dose vials | AMPP GTIN: 30380777700688 |
UK | 39373511000001104 | COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5mL dose suspension for injection multidose vials (Valneva UK Ltd) (product) | COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5mL dose suspension for injection multidose vials (Valneva UK Ltd) | AMP |
UK | 39374411000001100 | COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5mL dose suspension for injection multidose vials (Valneva UK Ltd) 10 dose (product) | COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5mL dose suspension for injection multidose vials (Valneva UK Ltd) 10 dose | AMPP |
UK | 39374711000001106 | COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5mL dose suspension for injection multidose vials (Valneva UK Ltd) 100 dose 10 x 10 dose vials (product) | COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5mL dose suspension for injection multidose vials (Valneva UK Ltd) 100 dose 10 x 10 dose vials | AMPP GTIN:09120040710330 |
UK | 39473011000001103 (no link yet available) | not yet available | COVID-19 Vaccine Novavax (adjuvanted) 5micrograms/0.5ml dose suspension for injection multidose vials (Baxter Oncology GmbH) | AMP |
UK | 39473111000001102 (no link yet available) | not yet available | COVID-19 Vaccine Novavax (adjuvanted) 5micrograms/0.5ml dose suspension for injection multidose vials (Baxter Oncology GmbH) 10 dose | AMPP |
UK | 39473211000001108 (no link yet available) | not yet available | COVID-19 Vaccine Novavax (adjuvanted) 5micrograms/0.5ml dose suspension for injection multidose vials (Baxter Oncology GmbH) 100 dose 10 x 10 dose vials | AMPP GTIN: 00380631100103 |
ES | 69961000122104 | COVID-19 adjuvant vaccine recombinant protein [Novavax] (medicinal product) | vacuna contra COVID-19 Adyuvada proteína recombinante [Novavax] (producto medicinal) | |
ES | 69971000122109 | COVID-19 adjuvant vaccine recombinant protein [Sanofi Pasteur / GSK] (medicinal product) | vacuna contra COVID-19 Adyuvada proteína recombinante [Sanofi Pasteur / GSK] (producto medicinal) | |
ES | 69911000122102 | mRNA COVID-19 vaccine [BioNTech / Pfizer] (medicinal product) | vacuna contra COVID-19 ARNm [BioNTech / Pfizer] (producto medicinal) | |
ES | 69921000122108 | mRNA COVID-19 vaccine [Curevac] (medicinal product) | vacuna contra COVID-19 ARNm [Curevac] (producto medicinal) | |
ES | 69931000122106 | mRNA COVID-19 vaccine [Moderna / Lonza] (medicinal product) | vacuna contra COVID-19 ARNm [Moderna / Lonza] | |
ES | 69941000122103 | COVID-19 vaccine with Ad26 vector [J&J / Janssen] (medicinal product) | vacuna contra COVID-19 con vector Ad26 [J&J / Janssen] (producto medicinal) | |
ES | 69951000122101 | COVID-19 vaccine with ChAdOx1 vector [Oxford / AstraZeneca] (medicinal product) | vacuna contra COVID-19 con vector ChAdOx1 [Oxford / AstraZeneca] (producto medicinal) | |
IE | 1401000220108 | COVID-19 Vaccine AstraZeneca 5 x10,000,000,000 viral particles per 0.5ml dose for injection multidose vials (medicinal product) | COVID-19 Vaccine AstraZeneca | |
IE | 1421000220104 | COVID-19 mRNA Vaccine Moderna 0.1mg per 0.5mL dose dispersion for injection multidose vials (medicinal product) | COVID-19 mRNA Vaccine Moderna | |
IE | 1411000220106 | COVID-19 mRNA Vaccine Pfizer-BioNTech 30 micrograms per 0.3ml dose concentrate for suspension for injection multidose vials (medicinal product) | COVID-19 mRNA Vaccine Pfizer-BioNTech | |
IE | 1591000220103 (no link yet available) | Janssen COVID-19 Vaccine 0.5 millilitre suspension injection Janssen Inc (medicinal product) | COVID-19 Janssen Vaccine | |
IN | 997231000189107 | Covishield 0.5 milliliter/1 dose solution for injection Serum Institute of India Private Limited (real clinical drug) | Covishield vaccine | |
IN | 997201000189104 | Covaxin 0.5 milliliter/1 dose solution for injection Bharat Biotech International Limited (real clinical drug) | Covaxin vaccine | |
IN | 997261000189100 | Sputnik V 0.5 milliliter/1 dose solution for injection Dr.Reddy's Laboratories Limited (real clinical drug | Sputnik V vaccine | |
IN | 997271000189109 | Sputnik V 0.5 milliliter/1 dose solution for injection Panacea Biotec Limited (real clinical drug) | Sputnik V vaccine | |
CA | COMIRNATY messenger ribonucleic acid 10 micrograms per 0.2 milliliter suspension for injection BioNTech Manufacturing GmbH (real clinical drug) | COVID-19 COMIRNATY pediatric 10 mcg/0.2 ml mRNA PB | ||
CA | COMIRNATY messenger ribonucleic acid 3 micrograms per 0.2 milliliter suspension for injection BioNTech Manufacturing GmbH (real clinical drug | COVID-19 COMIRNATY pediatric 3 mcg/0.2 ml mRNA PB | ||
CA | COMIRNATY messenger ribonucleic acid 30 micrograms per 0.3 milliliter suspension for injection BioNTech Manufacturing GmbH (real clinical drug) | COVID-19 COMIRNATY 30 mcg/0.3 ml mRNA PB | ||
CA | COMIRNATY vaccine messenger ribonucleic acid 30 micrograms per 0.3 milliliter tris-sucrose formulation suspension for injection BioNTech Manufacturing GmbH (real clinical drug) | COVID-19 COMIRNATY tris-sucrose 30 mcg/0.3 ml mRNA PB | ||
CA | COVIFENZ virus-like particle 3.75 micrograms per 0.5 milliliter emulsion for injection Medicago Inc. (real clinical drug) | COVID-19 COVIFENZ VLP MED | ||
CA | COVISHIELD non-replicant vector 0.5 milliliter solution for injection Verity Pharmaceuticals Inc. (real clinical drug) | COVID-19 COVISHIELD VP | ||
CA | JANSSEN COVID-19 VACCINE non-replicant vector 0.5 milliliter suspension for injection Janssen Inc. (real clinical drug) | COVID-19 JANSSEN COVID-19 VACCINE Jan | ||
CA | NUVAXOVID recombinant spike protein 5 micrograms per 0.5 milliliter suspension for injection Novavax Inc. (real clinical drug) | COVID-19 NUVAXOVID NOV | ||
CA | SPIKEVAX Bivalent (Original / Omicron BA.1) messenger ribonucleic acid 0.10 milligrams per 1 milliliter dispersion for injection Moderna Therapeutics Inc. (real clinical drug) | COVID-19 SPIKEVAX Bivalent (Original / Omicron BA.1) 0.10 mg/mL mRNA Mod | ||
CA | SPIKEVAX Bivalent (Original / Omicron BA.4/BA.5) messenger ribonucleic acid 0.10 milligrams per 1 milliliter dispersion for injection Moderna Therapeutics Inc. (real clinical drug) | COVID-19 SPIKEVAX Bivalent (Original / Omicron BA.4/BA.5) 0.10 mg/mL mRNA Mod | ||
CA | SPIKEVAX messenger ribonucleic acid 0.10 milligrams per 1 milliliter dispersion for injection Moderna Therapeutics Inc. (real clinical drug) | COVID-19 SPIKEVAX 0.10 mg/mL mRNA Mod | ||
CA | SPIKEVAX messenger ribonucleic acid 0.20 milligrams per 1 milliliter dispersion for injection Moderna Therapeutics Inc. (real clinical drug) | COVID-19 SPIKEVAX 0.20 mg/mL mRNA Mod | ||
CA | VAXZEVRIA non-replicant vector 0.5 milliliter solution for injection AstraZeneca Canada Inc. (real clinical drug) | COVID-19 VAXZEVRIA AZC | ||
CA | COMIRNATY Original & Omicron BA.4/BA.5 messenger ribonucleic acid 30 micrograms per 0.3 milliliter suspension for injection BioNTech Manufacturing GmbH (real clinical drug) | COMIRNATY bivalent Original and Omicron BA.4/BA.5 30 mcg/0.3 mL mRNA | ||
CA | COMIRNATY Original & Omicron BA.4/BA.5 messenger ribonucleic acid 10 micrograms per 0.2 milliliter suspension for injection BioNTech Manufacturing GmbH (real clinical drug) | COVID-19 COMIRNATY Original & Omicron BA.4/BA.5 pediatric 10mcg/0.2mL PB | ||
CA | SPIKEVAX Bivalent (Original / Omicron BA.4/BA.5) messenger ribonucleic acid 10 micrograms per 0.2 milliliter dispersion for injection Moderna Therapeutics Inc. (real clinical drug) | COVID-19 SPIKEVAX Bivalent (Original / Omicron BA.4/BA.5) pediatric 10 mcg/0.2mL mRNA Mod | ||
CA | Pediatric vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (medicinal product) | COVID-19 pediatric mRNA unspecified | ||
CA | VidPrevtyn Beta recombinant spike protein 5 micrograms per 0.5 milliliter emulsion for injection Sanofi Pasteur Ltd. (real clinical drug) | COVID-19 VidPrevtyn Beta SP | ||
CA | COMIRNATY Original & Omicron BA.4/BA.5 messenger ribonucleic acid 3 micrograms per 0.2 milliliter suspension for injection BioNTech Manufacturing GmbH (real clinical drug) | COVID-19 COMIRNATY Original & Omicron BA.4/BA.5 pediatric 3 mcg/0.2mL mRNA PB | ||
CA | CORBEVAX recombinant spike protein 0.5 milliliter suspension for injection Biological E. Limited (real clinical drug) | COVID-19 CORBEVAX BE | ||
CA | NUVAXOVID Omicron XBB.1.5 recombinant spike protein 5 micrograms per 0.5 milliliter suspension for injection Novavax Inc. (real clinical drug) | COVID-19 NUVAXOVID Omicron XBB.1.5 NOV | ||
CA | COMIRNATY Omicron XBB.1.5 messenger ribonucleic acid 30 micrograms per 0.3 milliliter suspension for injection BioNTech Manufacturing GmbH (real clinical drug) | COVID-19 COMIRNATY Omicron XBB.1.5 30 mcg/0.3mL mRNA PB | ||
CA | SPIKEVAX XBB.1.5 messenger ribonucleic acid 0.10 milligrams per 1 milliliter dispersion for injection Moderna Biopharma Canada Corporation (real clinical drug) | COVID-19 SPIKEVAX XBB.1.5 0.10 mg/mL mRNA MBCC | ||
CA | COMIRNATY Omicron XBB.1.5 messenger ribonucleic acid 3 micrograms per 0.2 milliliter suspension for injection BioNTech Manufacturing GmbH (real clinical drug) | COVID-19 COMIRNATY Omicron XBB.1.5 pediatric 3 mcg/0.2 mL mRNA PB | ||
CA | COMIRNATY Omicron XBB.1.5 messenger ribonucleic acid 10 micrograms per 0.3 milliliter suspension for injection BioNTech Manufacturing GmbH (real clinical drug) | COVID-19 COMIRNATY Omicron XBB.1.5 pediatric 10 mcg/0.3 mL mRNA PB | ||
CA | 51621000087101 | COMIRNATY Omicron XBB.1.5 messenger ribonucleic acid 10 micrograms per 0.2 milliliter suspension for injection BioNTech Manufacturing GmbH (real clinical drug) | COVID-19 COMIRNATY Omicron XBB.1.5 pediatric 10 mcg/0.2 mL mRNA PB | |
AU | 1527311000168101 | chimpanzee adenovirus vector encoding severe acute respiratory syndrome coronavirus-2 spike glycoprotein (medicinal product) | COVID-19 ChAdOx1-S viral vector vaccine | |
AU | 1530511000168108 | chimpanzee adenovirus vector encoding severe acute respiratory syndrome coronavirus-2 spike glycoprotein 50 billion viral particles / 0.5 mL injection, 4 mL vial (medicinal product unit of use) | COVID-19 ChAdOx1-S viral vector vaccine, 4 mL vial | |
AU | 1527321000168108 | chimpanzee adenovirus vector encoding severe acute respiratory syndrome coronavirus-2 spike glycoprotein 50 billion viral particles / 0.5 mL injection, 5 mL vial (medicinal product unit of use) | COVID-19 ChAdOx1-S viral vector vaccine, 5 mL vial | |
AU | 1591871000168100 | Comirnaty Grey Cap 12 Years and Above Ready to Use Multidose (tozinameran 30 microgram / 0.3 mL) injection, 2.25 mL vial (trade product unit of use) | Comirnaty Grey Cap 12 Years and Above Ready to Use Multidose 30 microgram/0.3 mL injection, 2.25 mL vial | |
AU | 1656521000168106 | Comirnaty Maroon Cap 6 Months to less than 5 Years Dilute to Use Multidose (tozinameran) injection, 0.4 mL vial (trade product unit of use) | Comirnaty Maroon Cap 6 Months to less than 5 Years Dilute to Use Multidose injection, 0.4 mL vial | |
AU | 1591711000168100 | Comirnaty Orange Cap 5 to less than 12 Years Dilute to Use Multidose (tozinameran) injection, 1.3 mL vial (trade product unit of use) | Comirnaty Orange Cap 5 to less than 12 Years Dilute to Use Multidose injection, 1.3 mL vial | |
AU | 1640431000168105 | Comirnaty Original/Omicron BA.1 Multidose (riltozinameran 15 microgram / 0.3 mL + tozinameran 15 microgram / 0.3 mL) injection, 2.25 mL vial (trade product unit of use) | Comirnaty Original/Omicron BA.1 Multidose injection, 2.25 mL vial | |
AU | 1652631000168107 | Comirnaty Original/Omicron BA.4-5 Multidose (famtozinameran 15 microgram / 0.3 mL + tozinameran 15 microgram / 0.3 mL) injection, 2.25 mL vial (trade product unit of use) | Comirnaty Original/Omicron BA.4-5 Multidose injection, 2.25 mL vial | |
AU | 1525041000168106 | Comirnaty Purple Cap Multidose (tozinameran) injection, 0.45 mL vial (trade product unit of use) | Comirnaty Purple Cap Multidose injection, 0.45 mL vial | |
AU | 1655191000168105 | davesomeran + elasomeran (medicinal product) | elasomeran + davesomeran | |
AU | 1659041000168103 | davesomeran 25 microgram / 0.5 mL + elasomeran 25 microgram / 0.5 mL injection, 0.5 mL syringe (medicinal product unit of use) | elasomeran 25 microgram/0.5 mL + davesomeran 25 microgram/0.5 mL injection, syringe | |
AU | 1655201000168108 | davesomeran 25 microgram / 0.5 mL + elasomeran 25 microgram / 0.5 mL injection, 2.5 mL vial (medicinal product unit of use) | elasomeran 25 microgram/0.5 mL + davesomeran 25 microgram/0.5 mL injection, 2.5 mL vial | |
AU | 1565221000168102 | elasomeran (medicinal product) | elasomeran | |
AU | 1632651000168102 | elasomeran + imelasomeran (medicinal product) | elasomeran + imelasomeran | |
AU | 1636281000168108 | elasomeran 100 microgram / 1 mL injection, 2.5 mL vial (medicinal product unit of use) | elasomeran 100 microgram/mL injection, 2.5 mL vial | |
AU | 1565231000168104 | elasomeran 200 microgram / 1 mL injection, 5 mL vial (medicinal product unit of use) | elasomeran 200 microgram/mL injection, 5 mL vial | |
AU | 1632661000168100 | elasomeran 25 microgram / 0.5 mL + imelasomeran 25 microgram / 0.5 mL injection, 2.5 mL vial (medicinal product unit of use) | elasomeran 25 microgram/0.5 mL + imelasomeran 25 microgram/0.5 mL injection, 2.5 mL vial | |
AU | 1632711000168105 | elasomeran 25 microgram / 0.5 mL + imelasomeran 25 microgram / 0.5 mL injection, 5 mL vial (medicinal product unit of use) | elasomeran 25 microgram/0.5 mL + imelasomeran 25 microgram/0.5 mL injection, 5 mL vial | |
AU | 1652611000168102 | famtozinameran + tozinameran (medicinal product) | tozinameran + famtozinameran | |
AU | 1652621000168109 | famtozinameran 15 microgram / 0.3 mL + tozinameran 15 microgram / 0.3 mL injection, 2.25 mL vial (medicinal product unit of use) | tozinameran 15 microgram/0.3 mL + famtozinameran 15 microgram/0.3 mL injection, 2.25 mL vial | |
AU | 1595611000168109 | Nuvaxovid Multidose (severe acute respiratory syndrome coronavirus-2 recombinant spike protein (NVX-CoV2373) antigen 5 microgram / 0.5 mL) injection, 5 mL vial (trade product unit of use) | Nuvaxovid Multidose injection, 5 mL vial | |
AU | 1640411000168100 | riltozinameran + tozinameran (medicinal product) | tozinameran + riltozinameran | |
AU | 1640421000168107 | riltozinameran 15 microgram / 0.3 mL + tozinameran 15 microgram / 0.3 mL injection, 2.25 mL vial (medicinal product unit of use) | tozinameran 15 microgram/0.3 mL + riltozinameran 15 microgram/0.3 mL injection, 2.25 mL vial | |
AU | 1595591000168104 | severe acute respiratory syndrome coronavirus-2 recombinant spike protein (NVX-CoV2373) antigen (medicinal product) | COVID-19 (NVX-CoV2373) vaccine | |
AU | 1595601000168106 | severe acute respiratory syndrome coronavirus-2 recombinant spike protein (NVX-CoV2373) antigen 5 microgram / 0.5 mL injection, 5 mL vial (medicinal product unit of use) | COVID-19 (NVX-CoV2373) vaccine injection, 5 mL vial | |
AU | 1659051000168101 | Spikevax Bivalent Original/Omicron BA.4-5 (davesomeran 25 microgram / 0.5 mL + elasomeran 25 microgram / 0.5 mL) injection, 0.5 mL syringe (trade product unit of use) | Spikevax Bivalent Original/Omicron BA.4-5 injection, 0.5 mL syringe | |
AU | 1655211000168106 | Spikevax Bivalent Original/Omicron BA.4-5 Multidose (davesomeran 25 microgram / 0.5 mL + elasomeran 25 microgram / 0.5 mL) injection, 2.5 mL vial (trade product unit of use) | Spikevax Bivalent Original/Omicron BA.4-5 Multidose injection, 2.5 mL vial | |
AU | 1632671000168106 | Spikevax Bivalent Original/Omicron Multidose (elasomeran 25 microgram / 0.5 mL + imelasomeran 25 microgram / 0.5 mL) injection, 2.5 mL vial (trade product unit of use) | Spikevax Bivalent Original/Omicron Multidose injection, 2.5 mL vial | |
AU | 1632721000168103 | Spikevax Bivalent Original/Omicron Multidose (elasomeran 25 microgram / 0.5 mL + imelasomeran 25 microgram / 0.5 mL) injection, 5 mL vial (trade product unit of use) | Spikevax Bivalent Original/Omicron Multidose injection, 5 mL vial | |
AU | 1636291000168106 | Spikevax Multidose (elasomeran 100 microgram / 1 mL) injection, 2.5 mL vial (trade product unit of use) | Spikevax Multidose 100 microgram/mL injection, 2.5 mL vial | |
AU | 1565241000168108 | Spikevax Multidose (elasomeran 200 microgram / 1 mL) injection, 5 mL vial (trade product unit of use) | Spikevax Multidose 200 microgram/mL injection, 5 mL vial | |
AU | 1525021000168100 | tozinameran (medicinal product) | tozinameran | |
AU | 1591861000168106 | tozinameran 30 microgram / 0.3 mL injection, 2.25 mL vial (medicinal product unit of use) | tozinameran 30 microgram/0.3 mL injection, 2.25 mL vial | |
AU | 1656511000168104 | tozinameran injection, 0.4 mL vial (medicinal product unit of use) | tozinameran injection, 0.4 mL vial | |
AU | 1525031000168102 | tozinameran injection, 0.45 mL vial (medicinal product unit of use) | tozinameran injection, 0.45 mL vial | |
AU | 1591701000168103 | tozinameran injection, 1.3 mL vial (medicinal product unit of use) | tozinameran injection, 1.3 mL vial | |
AU | 1530521000168101 | Vaxzevria Multidose (chimpanzee adenovirus vector encoding severe acute respiratory syndrome coronavirus-2 spike glycoprotein 50 billion viral particles / 0.5 mL) injection, 4 mL vial (trade product unit of use) | Vaxzevria Multidose injection, 4 mL vial | |
AU | 1527331000168106 | Vaxzevria Multidose (chimpanzee adenovirus vector encoding severe acute respiratory syndrome coronavirus-2 spike glycoprotein 50 billion viral particles / 0.5 mL) injection, 5 mL vial (trade product unit of use) | Vaxzevria Multidose injection, 5 mL vial |
